Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeharu Yamanaka

Showing results (1-10 of 230) with videos related to

Pageof 23
Sort By:
Nihon Geka Gakkai Zasshi|April 16, 2016
[PRIMER FOR SURGICAL CLINICAL TRIALS]Kentaro Sakamaki, Takeharu Yamanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Using Real World Data in Cancer Clinical Studies]Takeharu Yamanaka, Kentaro Yamazaki, Tetsutaro Hamano
Annals of Surgical Oncology|January 6, 2019
Reply to: "Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?", by Marino, Elisabetta et alYoshiaki Nakamura, Takeharu Yamanaka, Kohei Shitara
The New England Journal of Medicine|November 9, 2018
Sunitinib Alone or after Nephrectomy in Renal CancerChihiro N Kondoh, Yuji Miura, Takeharu Yamanaka
JTO Clinical and Research Reports|September 30, 2021
Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in <i>EGFR</i>-Mutated Lung CancerNaoki Haratake, Toshihiro Misumi, Takeharu Yamanaka, et al.
Biometrics|August 8, 2007
Sample size calculations based on ranking and selection in microarray experimentsShigeyuki Matsui, Shu Zeng, Takeharu Yamanaka, et al.
BMC Cancer|August 2, 2012
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG 5910L)Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, et al.
Journal of Surgical Oncology|December 21, 2007
The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinomaManabu Yamamoto, Takeharu Yamanaka, Hideo Baba, et al.
International Journal of Clinical Oncology|July 20, 2006
Methodological aspects of current problems in target-based anticancer drug developmentTakeharu Yamanaka, Tatsuro Okamoto, Yukito Ichinose, et al.
Clinical Lung Cancer|July 3, 2017
Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study ProtocolNobuyuki Yamamoto, Hirotsugu Kenmotsu, Takeharu Yamanaka, et al.
Pageof 23

Showing results (1-10 of 230) with videos related to

Sort By:
Pageof 23
Nihon Geka Gakkai Zasshi|April 16, 2016
[PRIMER FOR SURGICAL CLINICAL TRIALS]Kentaro Sakamaki, Takeharu Yamanaka
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 3, 2020
[Using Real World Data in Cancer Clinical Studies]Takeharu Yamanaka, Kentaro Yamazaki, Tetsutaro Hamano
Annals of Surgical Oncology|January 6, 2019
Reply to: "Multimodal Treatment of Locally Advanced Gastric Cancer: Will the West Meet the East?", by Marino, Elisabetta et alYoshiaki Nakamura, Takeharu Yamanaka, Kohei Shitara
The New England Journal of Medicine|November 9, 2018
Sunitinib Alone or after Nephrectomy in Renal CancerChihiro N Kondoh, Yuji Miura, Takeharu Yamanaka
JTO Clinical and Research Reports|September 30, 2021
Optimizing Sequential Treatment With EGFR Tyrosine Kinase Inhibitor With a Simulation of the T790M Mutation Rate in <i>EGFR</i>-Mutated Lung CancerNaoki Haratake, Toshihiro Misumi, Takeharu Yamanaka, et al.
Biometrics|August 8, 2007
Sample size calculations based on ranking and selection in microarray experimentsShigeyuki Matsui, Shu Zeng, Takeharu Yamanaka, et al.
BMC Cancer|August 2, 2012
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG 5910L)Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, et al.
Journal of Surgical Oncology|December 21, 2007
The postoperative recurrence and the occurrence of second primary carcinomas in patients with early gastric carcinomaManabu Yamamoto, Takeharu Yamanaka, Hideo Baba, et al.
International Journal of Clinical Oncology|July 20, 2006
Methodological aspects of current problems in target-based anticancer drug developmentTakeharu Yamanaka, Tatsuro Okamoto, Yukito Ichinose, et al.
Clinical Lung Cancer|July 3, 2017
Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study ProtocolNobuyuki Yamamoto, Hirotsugu Kenmotsu, Takeharu Yamanaka, et al.
Pageof 23